Holdings of Swedbank Robur Healthcare
Swedbank Robur Fonder AB · Original filing · Compare with another fund · Report an error
- Net assets
- 14.2B SEK including 13.9B SEK in equities, 97.8 %
- Positions
- 63 in 13 countries
- Top ten
- 55.3 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 144,500 | 1.3B SEK | 8.90 % |
| 2 | AstraZeneca PLC | 633,657 | 1.2B SEK | 8.22 % |
| 3 | AbbVie Inc | 466,050 | 965.6M SEK | 6.79 % |
| 4 | Merck & Co Inc | 832,000 | 953.4M SEK | 6.70 % |
| 5 | Thermo Fisher Scientific Inc | 150,050 | 702.6M SEK | 4.94 % |
| 6 | Johnson & Johnson | 293,400 | 683.2M SEK | 4.80 % |
| 7 | Gilead Sciences Inc | 486,349 | 645.7M SEK | 4.54 % |
| 8 | McKesson Corp | 70,620 | 582.2M SEK | 4.09 % |
| 9 | STERIS PLC | 219,350 | 462.1M SEK | 3.25 % |
| 10 | Vertex Pharmaceuticals Inc | 101,700 | 432.6M SEK | 3.04 % |
| 11 | Cencora Inc | 141,686 | 424M SEK | 2.98 % |
| 12 | Royalty Pharma PLC | 872,550 | 398.7M SEK | 2.80 % |
| 13 | Boston Scientific Corp | 654,994 | 391.5M SEK | 2.75 % |
| 14 | Cigna Group/The | 143,850 | 365.5M SEK | 2.57 % |
| 15 | HCA Healthcare Inc | 69,900 | 315.1M SEK | 2.22 % |
| 16 | Swedish Orphan Biovitrum AB | 766,349 | 300.6M SEK | 2.11 % |
| 17 | UCB SA | 97,027 | 275.3M SEK | 1.94 % |
| 18 | Tenet Healthcare Corp | 147,954 | 266M SEK | 1.87 % |
| 19 | Roche Holding AG | 68,713 | 256.4M SEK | 1.80 % |
| 20 | Intuitive Surgical Inc | 54,500 | 239.3M SEK | 1.68 % |
| 21 | Jazz Pharmaceuticals PLC | 113,313 | 204.1M SEK | 1.43 % |
| 22 | UnitedHealth Group Inc | 72,850 | 187.8M SEK | 1.32 % |
| 23 | Abbott Laboratories | 179,050 | 175.1M SEK | 1.23 % |
| 24 | Chugai Pharmaceutical Co Ltd | 313,000 | 161.4M SEK | 1.13 % |
| 25 | Agilent Technologies Inc | 137,750 | 149.6M SEK | 1.05 % |
| 26 | Globus Medical Inc | 172,403 | 141.5M SEK | 0.99 % |
| 27 | Camurus AB | 274,957 | 128.4M SEK | 0.90 % |
| 28 | Novo Nordisk A/S | 358,186 | 121.5M SEK | 0.85 % |
| 29 | Halozyme Therapeutics Inc | 160,662 | 98.9M SEK | 0.70 % |
| 30 | Neurocrine Biosciences Inc | 77,300 | 97M SEK | 0.68 % |
| 31 | Convatec Group PLC | 3,100,000 | 83.9M SEK | 0.59 % |
| 32 | Argenx SE | 11,470 | 78.2M SEK | 0.55 % |
| 33 | BioMarin Pharmaceutical Inc | 133,750 | 72M SEK | 0.51 % |
| 34 | Fresenius SE & Co. KGaA | 145,532 | 70.8M SEK | 0.50 % |
| 35 | Natera Inc | 35,450 | 67.5M SEK | 0.47 % |
| 36 | Align Technology Inc | 40,200 | 65.7M SEK | 0.46 % |
| 37 | Cooper Cos Inc/The | 89,000 | 60.6M SEK | 0.43 % |
| 38 | Medistim ASA | 287,984 | 59.4M SEK | 0.42 % |
| 39 | Insulet Corp | 29,400 | 58.8M SEK | 0.41 % |
| 40 | Ensign Group Inc/The | 30,000 | 57.6M SEK | 0.40 % |
| 41 | RaySearch Laboratories AB | 253,001 | 48.4M SEK | 0.34 % |
| 42 | Carasent AB | 2,055,000 | 47.2M SEK | 0.33 % |
| 43 | Sectra AB | 185,996 | 42.1M SEK | 0.30 % |
| 44 | BioNTech SE | 46,200 | 39.1M SEK | 0.28 % |
| 45 | BioArctic AB | 118,693 | 38M SEK | 0.27 % |
| 46 | Savara Inc | 700,000 | 36.4M SEK | 0.26 % |
| 47 | Sartorius AG | 14,963 | 34.8M SEK | 0.24 % |
| 48 | ICON PLC | 32,150 | 33.9M SEK | 0.24 % |
| 49 | Rapport Therapeutics Inc | 113,200 | 33.7M SEK | 0.24 % |
| 50 | Mineralys Therapeutics Inc | 122,100 | 31.5M SEK | 0.22 % |
| 51 | Newamsterdam Pharma Co NV | 100,900 | 30.8M SEK | 0.22 % |
| 52 | Chemometec A/S | 68,455 | 30.2M SEK | 0.21 % |
| 53 | ALK-Abello A/S | 100,181 | 29.8M SEK | 0.21 % |
| 54 | Indivior Pharmaceuticals Inc | 95,000 | 27.6M SEK | 0.19 % |
| 55 | Zealand Pharma A/S | 60,582 | 26.3M SEK | 0.18 % |
| 56 | Egetis Therapeutics AB (publ) | 4,750,000 | 26.1M SEK | 0.18 % |
| 57 | Ionis Pharmaceuticals Inc | 32,253 | 23.1M SEK | 0.16 % |
| 58 | Bridgebio Pharma Inc | 27,600 | 19.5M SEK | 0.14 % |
| 59 | UFP Technologies Inc | 10,000 | 18.4M SEK | 0.13 % |
| 60 | Getinge AB | 85,218 | 16.1M SEK | 0.11 % |
| 61 | Herantis Pharma | 888,168 | 15.6M SEK | 0.11 % |
| 62 | Xenon Pharmaceuticals Inc | 26,200 | 14.5M SEK | 0.10 % |
| 63 | Olema Pharmaceuticals Inc | 55,100 | 7.8M SEK | 0.06 % |
Sector breakdown
- Health care 77.2 %
- Unattributed 22.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- SEK 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 75.7 %
- United Kingdom 9.0 %
- Sweden 4.7 %
- Belgium 2.5 %
- Switzerland 1.8 %
- Ireland 1.7 %
- Denmark 1.5 %
- Japan 1.2 %
- Germany 1.0 %
- Norway 0.4 %
- Netherlands 0.2 %
- Finland 0.1 %
- Other countries 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 36 | 10.5B SEK | 75.68 % |
| 2 | United Kingdom | 2 | 1.3B SEK | 9.01 % |
| 3 | Sweden | 8 | 646.8M SEK | 4.65 % |
| 4 | Belgium | 2 | 353.5M SEK | 2.54 % |
| 5 | Switzerland | 1 | 256.4M SEK | 1.84 % |
| 6 | Ireland | 2 | 238M SEK | 1.71 % |
| 7 | Denmark | 4 | 207.7M SEK | 1.49 % |
| 8 | Japan | 1 | 161.4M SEK | 1.16 % |
| 9 | Germany | 3 | 144.7M SEK | 1.04 % |
| 10 | Norway | 1 | 59.4M SEK | 0.43 % |
| 11 | Netherlands | 1 | 30.8M SEK | 0.22 % |
| 12 | Finland | 1 | 15.6M SEK | 0.11 % |
Cite this page
Titelia. "Holdings of Swedbank Robur Healthcare". https://titelia.com/en/funds/SE51586